Vox Sanguinis

Article	Citations
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group	110
Impact of the COVID‐19 pandemic on blood supply and demand in the WHO African Region	42
Neonatal red blood cell transfusion	33
Blood donation in times of crisis: Early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries	32
The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusion	30
Research initiatives of blood services worldwide in response to the covid‐19 pandemic	26
COVID‐19 convalescent plasma therapy: hit fast, hit hard!	24
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic	23
ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population	20
Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices	19
Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: A meta‐analysis of randomized controlled trials	18
Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)‐positive blood products to Rh(D)‐negative children	18
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma	18
Motivation, blood donor satisfaction and intention to return during the COVID‐19 pandemic	18
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems	16
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary	16
Estimating the risks of prehospital transfusion of D‐positive whole blood to trauma patients who are bleeding in England	15
A pilot randomized clinical trial of cryopreserved versus liquid‐stored platelet transfusion for bleeding in cardiac surgery: The cryopreserved versus liquid platelet‐New Zealand pilot tria	14
Blood donation by men who have sex with men: using evidence to change policy	14
Exchange transfusions in severe Rh‐mediated alloimmune haemolytic disease of the foetus and newborn: a 20‐year overview on the incidence, associated risks and outcome	13
Incidence of anti‐D alloimmunization in D‐negative individuals receiving D‐positive red blood cell transfusion: A systematic review and meta‐analysis	12
Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance	12
Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma	12
Activity‐based cost of platelet transfusions in medical and surgical inpatients at a US hospital	11
Assessing the inactivation capabilities of two commercially available platelet component pathogen inactivation systems: effectiveness at end of shelf life	11

Clinical consequences of the extremely rare anti‐PP1Pk isoantibodies in pregnancy: a case series and review of the literature	10
Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop	10
International Forum on Policies and Practice for Transfusion of ABO and RhD Non‐Identical Platelets: Summary	9
The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update	9
Prediction and impact of personalized donation intervals	9
Current status of rapid bacterial detection methods for platelet components: A 20‐year review by the ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria	9
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men	9
Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic	9
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?	9
Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulati	9
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology	9
Impact of disasters on blood donation rates and blood safety: A systematic review and meta‐analysis	9
Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study	9
Anti‐A and SARS‐CoV‐2: an intriguing association	9
The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre	9
Establishment of transfusion‐relevant bacteria reference strains for red blood cells	9
Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID‐19 pandemic in Cameroon	8
Recommendations for in vitro evaluation of blood components collected, prepared and stored in non‐DEHP medical devices	8
ISBT 2022 ‐ Abstract Book	8
Association of the ABO blood group with SARS‐CoV‐2 infection in a community with low infection rate	8
Red blood cell alloimmunization among recipients of blood transfusion in India: A systematic review and meta‐analysis	8
Impact of COVID‐19 on blood donor deferral patterns during the COVID‐19 pandemic: A retrospective analysis	8
Abstract	8
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID‐19: A qualitative study	8
International survey of strategies to mitigate transfusion‐transmittedTrypanosoma cruzi in non‐endemic countries, 2016–2018	8
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)	8
Abstract	8
Residual risks of bacterial contamination for pathogen‐reduced platelet components	8
Deferasirox‐associated Fanconi syndrome in adult patients with transfusional iron overload	7
Management of blood transfusion services in low‐resource countries	7
An open‐source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing	7
Determinants of intention to return to donate blood among first‐time blood donors in Ghana	7
Early packed red blood cell transfusion in major trauma patients: Evaluation and comparison of different prediction scores for massive transfusion	7
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey	7
International Forum on the Management of Major Haemorrhage: Summary	7
Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia	7
Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium	7
The impact of donor ferritin testing on blood availability in Canada	7
Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors	7
Determinants of the intention to participate in a programme of plasma donation for fractionation among men who have sex with men	7
Physician autonomy and patient rights: lessons from an enforced blood transfusion and the role of patient blood management	7
A case of Philadelphia chromosome‐positive acute lymphocytic leukaemia with type I CD36 deficiency	6
Blood transfusion activity in a general hospital during the COVID‐19 pandemic	6
Preventing alloimmunization using a new model for matching extensively typed red blood cells	6
A discrete‐event simulation model for analysing and improving operations in a blood donation centre	6
Blood donor eligibility criteria for medical conditions: A BEST collaborative study	6
Qualifying coronavirus disease 2019 convalescent plasma donors in Israel	6
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis	6
Preventing transfusion‐transmitted malaria in France	6
The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers	6

First annual report of Chinese haemovigilance network	6
Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10 years' experience	6
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method	6
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry	6
Plasma transfusion practices: A multicentre electronic audit	6
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review	6
Time–temperature indicators versus temperature indicators for transfusion practice: Application in the real hospital setting	6
Sequence variants in the proximal promoter and +5.8‐kb site of ABO in Koreans with weak B phenotypes	6
Platelet transfusion and mortality in patients with sepsis‐induced thrombocytopenia: A propensity score matching analysis	6
Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men	6
The impact of revised definitions for transfusion‐associated circulatory overload and transfusion‐related acute lung injury on haemovigilance reporting	6
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study	6
Dose‐dependent effects of red blood cell transfusion and case mix index on venous thromboembolic events in spine surgery	6
High false discovery rate of the Architect anti‐HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing	5
An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study	5
Characterization of health issues in young first‐time blood donors	5
Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men	5
COVID‐19 convalescent plasma: Evolving strategies for serological screening in France	5
Efficacy of therapeutic plasma exchange in severe COVID‐19 disease: A meta‐analysis	5
High‐titre anti‐SARS‐CoV‐2 convalescent plasma donation after donors’ vaccination	5
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies	5
Patterns of red‐cell transfusion use in obstetric practice in Sweden 2003‐2017: A nationwide study	5
An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers	5
International Forum on Gender Identification and Blood Collection: Summary	5
Polycythaemia vera: molecular genetics, diagnostics and therapeutics	5
Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight	5
Evolving the gay, bisexual and other men who have sex with men time‐based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes	5
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 2022	5
Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variantCreutzfeldt–Jakobdisease	5
Use of selective phenotyping and genotyping to identify rare blood donors in Canada	5
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project	5
Filariasis and transfusion‐associated risk: a literature review	5
Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers	5
The history of buffy coat platelet concentrates: The Dutch story	5
Impacts of COVID‐19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia	5
Does ABO blood group influence antibody response to SARS‐CoV‐2 vaccination?	5
Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies	5
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial	5
Low neutralization capacity against SARS‐CoV‐2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1	5
Mortality and outcomes by blood group in trauma patients: A systematic review and meta‐analysis	5
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral	4
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy	4
ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother	4
Use of computational biology to compare the theoretical tertiary structures of the most common forms of RhCE and RhD	4
Safety and protection of plasma donors: A scoping review and evidence gap map	4
Detection and phenotype analysis of a novel Ael blood group allele	4
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary	4
Short‐term high‐dose intravenous iron reduced peri‐operative transfusion after staggered bilateral total knee arthroplasty: A retrospective cohort study	4
Immediate intravenous iron administration improves anaemia recovery following total knee arthroplasty: A propensity‐matched analysis	4
The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration	4
Clinical and in vitro evaluation of red blood cells collected and stored in a non‐DEHP plasticized bag system	4
Development and evaluation of a community of practice to improve stem cell donor recruitment in Canada	4
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study	4
Platelet transfusion is associated with 90‐day and 1‐year mortality for adult patients requiring veno‐arterial extracorporeal membrane oxygenation	4
Reduced neutralizing antibody potency of COVID‐19 convalescent vaccinated plasma against SARS‐CoV‐2 Omicron variant	4
DEHT is a suitable plasticizer option for phthalate‐free storage of irradiated red blood cells	4
Impact of restrictive red blood cell transfusion strategy on thrombosis‐related events: A meta‐analysis and systematic review	4
Frequency and timing of all‐cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances	4
Adverse events caused by cord blood infusion in Japan during a 5‐year period	4
Application of unsupervised machine learning to identify areas of blood product wastage in transfusion medicine	4
A comparison of the effect of X and gamma irradiation on red cell storage quality	4
Implementation of amotosalen plus ultraviolet A‐mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections	4
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply	4
Rapid genotyping of 508G>A (rs3745635) and 1067T>A (rs3894326) of FUT3 by a duplex Eprobe‐mediated melting curve analysis	4
White paper on pandemic preparedness in the blood supply	4
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure	4
The impact of the COVID‐19 outbreak on activation of the massive transfusion protocol in the emergency department	4
Validation of a standardized donor health questionnaire across substances of human origin	4
Altered strategy of prophylactic anti‐D administration in pregnancy to cover term and post‐term – a pilot study	4
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries	4
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays	4
Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review	4
Optimization of diagnostic strategy for non‐invasive cell‐free foetal RHD determination from maternal plasma	4
Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020	4
Evaluation of the Sysmex XN‐31 automated analyser for blood donor malaria screening at Malawi Blood Transfusion Services	4
Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility	4
Use of O RhD‐negative red blood cells: A nationwide, prospective audit	4
Plasma, platelet and red blood cell transfusion ratios for life‐threatening non‐traumatic haemorrhage in medical and post‐surgical patients: An observational study	4
Does cold storage of blood before transfusion prevent the transmission of syphilis? A systematic review and meta‐analysis	3
Iron supplementation: A qualitative study on the perception of blood donors, blood collection staff and donor physicians	3

Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis	3
What influences decisions to donate plasma? A rapid review of the literature	3
Modelling the outcomes of different red blood cell transfusion strategies for the treatment of traumatic haemorrhage in the prehospital setting in the United Kingdom	3
Inequality averse and compassionate blood donor: implication for interventions	3
Is there an optimal trade‐off between anaemia and red blood cell transfusion in surgical critically ill patients after oncologic surgery?	3
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study	3
Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID‐19 in Brazil	3
Blood component ratios in children with non‐traumatic life‐threatening bleeding	3
Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation	3
Using competition for plasma donor recruitment and retention: An Australian university case study	3
Changes in Parvovirus B19 positivity rates in plasma units for fractionation: An unexpected effect of non‐pharmaceutical interventions against COVID‐19?	3
Non‐severe allergic transfusion reaction: A hidden cause of wastage of blood product and laboratory resources	3
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance	3
West Nile virus and blood transfusion safety: A European perspective	3
A randomized study of a best practice alert for platelet transfusions	3
MATRA‐A: A study on massive transfusion	3
COVID‐19 infection and complications according to ABO blood group in the elderly: A population‐based subcohort and meta‐analysis	3
Estimation of the latent therapeutic demand for immunoglobulin therapies in autoimmune neuropathies in the United States	3
A review of electronic medical records and safe transfusion practice for guideline development	3
A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis	3
Therapeutic granulocyte infusion for patients with severe neutropaenia and neutrophilic dysfunction: New Zealand experience	3
The use of social media as a tool for patient blood management and transfusion medicine education	3
Challenging the 30‐min rule for thawed plasma	3
Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors	3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro	3
Contamination of platelet concentrates with Staphylococcus aureus induces significant modulations in platelet functionality	3
Blood donation behaviour and attitudes towards the 12‐month deferral policy among gay and bisexual men in New Zealand	3
Molecular blood group screening in Omani blood donors	3
An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation	3
The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients	3
Low‐dose prophylaxis and its impact on the health of haemophilia patients	3
Ludwik Hirszfeld: A pioneer of transfusion and immunology during the world wars and beyond	3
Plasma resuscitation improves and restores intestinal microcirculatory physiology following haemorrhagic shock	3
Factors affecting need for blood transfusion in paediatric patients undergoing open surgery for hip dysplasia	3
Subjects with blood group O are not at lower risk to acquire SARS‐CoV‐2 infection	3
Utility of reticulocyte haemoglobin content and immature reticulocyte fraction in early diagnosis of latent iron deficiency in whole blood donors	3
Is intravenous immunoglobulin a risk factor for necrotizing enterocolitis in neonates with haemolytic disease of the newborn? A retrospective cohort study	3
A novel quantitative method to evaluate the contribution of platelet products to white thrombus formation in reconstituted blood under flow conditions	3
Climate change: A call for action, even for Vox Sanguinis	3
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease	3
Comparison between tube test and automated column agglutination technology on VISION Max for anti‐A/B isoagglutinin titres: A multidimensional analysis	3
Profile of the single‐use, multiple‐pass protein A adsorber column in immunoadsorption	3
An international comparison of haemoglobin deferral prediction models for blood banking	3
Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill	3
Degree of blood safety of voluntary non‐remunerated versus replacement blood donations: A multi‐centre study of the large cohort of blood donors from two provinces of Pakistan	3
International Forum on Home‐Based Blood Transfusion: Summary	3
Low ferritin levels appear to be associated with worsened health in male repeat blood donors	3
Weak D type 42: Antigen density and risk of alloimmunization in the province of Québec	3
In vitro quality of cold and delayed cold‐stored platelet concentrates from interim platelet units during storage for 21 days	3